SEC recommends EUA for Covaxin from Bharat Biotech
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lymphoma drug, pralatrexate outperforms remdesivir against COVID-19: Study
However, this chemotherapy drug can prompt significant side effects so immediate use for COVID-19 patients is not guaranteed, said…
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the…
Wallace Pharma sets up R&D Centre in Goa
The facility will have a special focus on new drug delivery systems (NDDS)
Alniche Lifesciences forays into pharma manufacturing as EffiKasia Lifesciences
It will manufacture pharmaceuticals, nutraceuticals and dermatologicals from its facility in Kangra, Himachal Pradesh
SEC recommends EUA for Covishield, DCGI nod awaited
The SEC is also looking at the EUA applications of Pfizer and Bharat Biotech
CBIC relaxes rules for courier import and export of COVID-19 vaccines
Also instructs customs authorities to form a task force to enable speedy customs clearance of COVID-19 vaccines
Dry run for COVID-19 vaccine roll out in all States/UTs on January 2, 2021
The activity is proposed to be conducted in all state capitals in at least three session sites; Maharashtra and Kerala are likely…
FDI in brownfield pharma projects – Critical analysis
Arvind Sharma, Partner, Shardul Amarchand Mangaldas & Co informs that the extant regulatory regime for FDI in brownfield…
Glenmark gets final nod for Tadalafil Tablets and tentative approvals for Gabapentin Enacarbil ER…
Glenmark’s current portfolio consists of 167 products authorised for distribution in the US marketplace
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the…
Minister of Chemicals and Fertilisers encourages industry to avail Phase II PLI scheme benefits
The scheme will be designed to benefit MSMEs along with large players
SEC meets to discuss EUA applications from Pfizer, SII and Bharat Biotech
To reconvene on Jan 1, 2021
We help our customers create future-ready pharma manufacturing and biotech facilities
Sanjay Sudhakaran, VP, Digital Energy, Schneider Electric India expands on the value proposition of digital energy systems for the…
Awaiting India’s approval for COVISHIELD: SII
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March
HMD completes order of 140 mn KOJAK AD Syringes for global COVID-19 vaccination campaigns
The company has shipped the last batch of 35 million pieces of KOJAK Auto Disable Syringes to Covax stockpile facility via UNICEF
Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021
Vaccines in pipeline will work against the new COVID-19 variants: Dr K Raghavan
Committee of experts to soon give report on the process of identifying and prioritising patients with co-morbidities, for the…